NZS Capital LLC Grows Stock Holdings in Intuitive Surgical, Inc. $ISRG

NZS Capital LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 61.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 110,014 shares of the medical equipment provider’s stock after acquiring an additional 41,708 shares during the period. Intuitive Surgical makes up 1.5% of NZS Capital LLC’s portfolio, making the stock its 26th biggest position. NZS Capital LLC’s holdings in Intuitive Surgical were worth $49,202,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in ISRG. Rossmore Private Capital increased its holdings in Intuitive Surgical by 2.0% in the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after purchasing an additional 20 shares in the last quarter. Activest Wealth Management boosted its position in shares of Intuitive Surgical by 21.7% in the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after buying an additional 20 shares during the period. Vertex Planning Partners LLC grew its stake in shares of Intuitive Surgical by 2.3% in the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock valued at $498,000 after buying an additional 21 shares in the last quarter. Accredited Investors Inc. raised its holdings in shares of Intuitive Surgical by 2.0% during the 3rd quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider’s stock valued at $474,000 after buying an additional 21 shares during the period. Finally, SPC Financial Inc. lifted its position in Intuitive Surgical by 1.3% during the 3rd quarter. SPC Financial Inc. now owns 1,614 shares of the medical equipment provider’s stock worth $722,000 after acquiring an additional 21 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Completed acquisition and direct operations in Southern Europe (Italy, Spain, Portugal, Malta, San Marino and territories), intended to give Intuitive closer access to hospitals and accelerate system, service and consumable sales; deal reported with about €319M upfront consideration. Intuitive Expands Investment and Footprint in Europe
• Positive Sentiment: Company may begin monetizing its My Intuitive+ digital platform in 2026 as renewals scale, creating a new recurring, software-driven revenue stream that could improve revenue visibility and margins over time. Can Digital Subscriptions Become ISRG’s New Revenue Stream in 2026?
• Positive Sentiment: Brokerage coverage summary remains constructive with a consensus “Moderate Buy” recommendation, supporting investor sentiment and providing a baseline for buy-side interest. Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Consensus Recommendation of “Moderate Buy” by Brokerages
• Positive Sentiment: Industry narratives around AI accelerating robotics adoption continue to include ISRG as a beneficiary — reinforcing the long-term growth story as the company layers AI and software onto its installed base. 5 Stocks Racing Ahead as AI Supercharges Robotics (ISRG)
• Neutral Sentiment: Media attention and “trending stock” coverage highlight retail and research interest but don’t directly change fundamentals; worth monitoring for short-term volume and volatility. Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
• Negative Sentiment: Some coverage flags investor questions about growth and near-term implications of the Southern Europe takeover — potential integration costs, local execution risk, and short-term margin pressure could temper near-term results. Intuitive Surgical Expands Southern Europe Reach And Raises Questions For Growth

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $497.42 on Wednesday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $603.88. The company has a market capitalization of $176.65 billion, a price-to-earnings ratio of 63.04, a price-to-earnings-growth ratio of 3.83 and a beta of 1.66. The company’s fifty day moving average price is $526.56 and its two-hundred day moving average price is $512.18.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the previous year, the firm earned $2.21 EPS. The company’s revenue was up 18.8% on a year-over-year basis. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 133 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the transaction, the vice president owned 660 shares of the company’s stock, valued at $326,673.60. This trade represents a 16.77% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Mark Brosius sold 464 shares of Intuitive Surgical stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the transaction, the senior vice president owned 131 shares of the company’s stock, valued at approximately $71,852.19. The trade was a 77.98% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 33,603 shares of company stock valued at $17,875,660 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of several recent research reports. UBS Group set a $570.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Tuesday, February 24th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 price target on shares of Intuitive Surgical in a research note on Friday, January 9th. HSBC boosted their price objective on shares of Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a report on Monday, January 26th. Finally, Sanford C. Bernstein raised their target price on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $615.86.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.